From the Guidelines
A person with a cavernous internal carotid artery aneurysm should not receive anti-coagulation for DVT prophylaxis due to the increased risk of aneurysm rupture and potentially catastrophic intracranial hemorrhage. According to the 2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage from the American Heart Association/American Stroke Association 1, the safety of pharmacological VTE prophylaxis in aSAH can be derived from clinical trials of pharmacological agents typically used for VTE prophylaxis, but the optimal timing of pharmacological VTE prophylaxis in aSAH relative to aneurysm occlusion and neurosurgical procedures remains unclear.
Some key points to consider in the management of DVT prophylaxis in patients with cavernous internal carotid artery aneurysm include:
- Mechanical DVT prophylaxis methods, such as sequential compression devices or graduated compression stockings, should be used instead of anticoagulation
- For patients at very high risk of DVT or pulmonary embolism, an inferior vena cava (IVC) filter might be considered as a temporary measure
- If anticoagulation is absolutely necessary due to high thrombotic risk, a multidisciplinary discussion involving neurosurgery, interventional neuroradiology, and hematology should occur to weigh individual risks and benefits
- The decision should consider factors such as aneurysm size, location, morphology, and whether the aneurysm is secured (treated with coiling or clipping), as noted in the context of aneurysmal subarachnoid hemorrhage management 1
- Early mobilization and adequate hydration should also be emphasized as non-pharmacological preventive measures for DVT prophylaxis.
The fundamental concern is that anticoagulants may increase the risk of bleeding from the aneurysm, which could lead to subarachnoid hemorrhage with significant morbidity and mortality, thus prioritizing the use of mechanical prophylaxis methods over anticoagulation in these patients.
From the Research
Cavernous Internal Carotid Artery Aneurysm and DVT Prophylaxis
- The provided studies do not directly address the use of anti-coagulation for DVT prophylaxis in patients with cavernous internal carotid artery aneurysms 2, 3, 4, 5, 6.
- These studies focus on the treatment and management of cavernous carotid artery aneurysms, including endovascular techniques, expectant management, and luminal preservation strategies 2, 3, 4.
- Some studies discuss the natural history and clinical presentation of cavernous carotid artery aneurysms, highlighting their unique characteristics and potential complications 4, 5, 6.
- One study mentions the development of spontaneous thrombosis of the aneurysm and parent artery occlusion in patients with positive balloon test occlusion, but does not provide guidance on anti-coagulation for DVT prophylaxis 6.
- There is no clear evidence to support or refute the use of anti-coagulation for DVT prophylaxis in patients with cavernous internal carotid artery aneurysms based on the provided studies.